14-23419950-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PP2PP3_ModeratePP5
The NM_000257.4(MYH7):c.3621C>G(p.Ile1207Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,457,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1207N) has been classified as Uncertain significance.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1SInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- MYH7-related skeletal myopathyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- myopathy, myosin storage, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- myopathy, myosin storage, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- congenital myopathy 7A, myosin storage, autosomal dominantInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ebstein anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hyaline body myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- left ventricular noncompactionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH7 | ENST00000355349.4 | c.3621C>G | p.Ile1207Met | missense_variant | Exon 27 of 40 | 1 | NM_000257.4 | ENSP00000347507.3 | ||
| MYH7 | ENST00000713768.1 | c.3621C>G | p.Ile1207Met | missense_variant | Exon 27 of 41 | ENSP00000519070.1 | ||||
| MYH7 | ENST00000713769.1 | c.3621C>G | p.Ile1207Met | missense_variant | Exon 26 of 39 | ENSP00000519071.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1457512Hom.: 0 Cov.: 35 AF XY: 0.0000179 AC XY: 13AN XY: 724814 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The I1207M likely pathogenic variant in the MYH7 gene has been previously reported in an individual with HCM progressing to heart failure and requiring a heart transplant, and was not detected in 800 control alleles (Melacini et al., 2010). The I1209M variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant occurs at a position that is conserved across species and in silico predictions this variant is probably damaging to the protein structure/function. Furthermore, missense variants in nearby residues (E1205K, D1208N, N1209S, Q1215H) have been reported in the Human Gene Mutation Database in association with cardiomyopathy (Stenson et al, 2014), supporting the functional importance of this region of the protein. However, the I1207M is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties.Therefore, this variant is a strong candidate for a pathogenic variant, however the possibility that it is a benign variant cannot be excluded. -
Hypertrophic cardiomyopathy 1 Pathogenic:1
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1207 of the MYH7 protein (p.Ile1207Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with dilated cardiomyopathy and/or hypertrophic cardiomyopathy (PMID: 20513729, 33019804). ClinVar contains an entry for this variant (Variation ID: 418363). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MYH7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.I1207M variant (also known as c.3621C>G), located in coding exon 25 of the MYH7 gene, results from a C to G substitution at nucleotide position 3621. The isoleucine at codon 1207 is replaced by methionine, an amino acid with highly similar properties. This variant has been detected in in an individual with hypertrophic cardiomyopathy (HCM) progressing to heart failure and transplant, and has also been detected in an individual from a dilated cardiomyopathy cohort; however, details were limited (Melacini P et al. Eur. Heart J., 2010 Sep;31:2111-23; Hey TM et al. Circ Heart Fail. 2020 10;13(10):e006701). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
MYH7-related disorder Uncertain:1
The MYH7 c.3621C>G (p.Ile1207Met) variant is a missense variant that has been reported in a heterozygous state in one individual with non-obstructive hypertrophic cardiomyopathy with preserved systolic function and atrial fibrillation who required a heart transplant at age 60 years (Melacini et al. 2010). This variant is not reported in version 2.1.1 or version 3.1.1 of the Genome Aggregation Database despite its location in a region of good sequencing coverage, suggesting it is rare. In silico algorithms are not consistent in their predictions of the functional effects of this variant. Based on the evidence, the p.Ile1207Met variant is classified as a variant of uncertain significance for MYH7-related disorders. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at